Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1C | P00326 | 3/20 | 0.48 |
| ▸ | ADH1A | P07327 | 3/20 | 0.48 |
| ▸ | ADH4 | P08319 | 2/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 5/20 | 0.42 |
| ▸ | ADH1B | P00325 | 2/20 | 0.39 |
| ▸ | ADH7 | P40394 | 2/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 2/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3954905 | 0.97 | ADH1C (0.52) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL5175186 | 0.97 | ADH1C (0.52) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL5479572 | 0.97 | ADH1C (0.52) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL276871 | 0.97 | ADH1C (0.52) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL3962903 | 0.97 | ADH1C (0.52) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL271668 | 0.97 | ADH1C (0.47) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL277587 | 0.97 | ADH1C (0.52) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL55195 | 0.97 | ADH1C (0.52) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL95389 | 0.97 | ADH1C (0.52) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL276848 | 0.97 | ADH1C (0.52) | ADH1CADH1AADH4DNM1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1815 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118344292-A | Acenaphthene derivative and preparation method thereof, acenaphthene derivative material and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-115304462-B | Method for producing glycolaldehyde | 中国石油大学(华东) | 2023-12-08 | — | — | CN | claimed |
| CN-114242953-B | Metallic lithium anode and preparation method and application thereof | 北京理工大学重庆创新中心 | 2023-07-21 | — | — | CN | claimed |
| CN-112010273-B | Carbon nitride material with terminal group carbonylation and preparation method thereof | 中国科学院大连化学物理研究所 | 2022-09-20 | — | — | CN | claimed |
| CN-109111352-B | Method for producing glycolaldehyde | 中国石油大学(华东) | 2022-07-05 | — | — | CN | claimed |
| CN-109641827-B | Method for the catalytic production of formic acid at low overpressure and for the regeneration of the catalyst used in the process | OXFA有限公司 | 2022-03-29 | — | — | CN | claimed |
| CN-114242953-A | Metallic lithium cathode and preparation method and application thereof | 北京理工大学重庆创新中心 | 2022-03-25 | — | — | CN | claimed |
| US-20210171515-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP. | 2021-06-10 | — | — | US | claimed |
| CN-112010273-A | Carbon nitride material with terminal group carbonylation and preparation method thereof | 中国科学院大连化学物理研究所 | 2020-12-01 | — | — | CN | claimed |
| EP-3484847-B1 | METHOD FOR SEPARATING FORMIC ACID FROM A REACTION MIXTURE BY MEANS OF EXTRACTION | OXFA GMBH (DE) | 2020-10-28 | — | — | EP | claimed |
| WO-2005012326-A1 | NOVEL COMPOUNDS HAVING INHIBITORY ACTIVITY AGAINST SODIUM-DEPENDANT TRANSPORTER | TANABE SEIYAKU CO., LTD. (JP) | 2005-02-10 | — | — | WO | claimed |
| WO-2005007631-A1 | NAPHTHYLENE DERIVATIVES AS CYTOCHROME P450 INHIBITORS | OSI PHARMACEUTICALS, INC. (US) | 2005-01-27 | — | — | WO | claimed |
| JP-2002501515-A | — | — | 2002-01-15 | — | — | JP | claimed |
| US-6313344-B1 | PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-11-06 | — | — | US | claimed |
| EP-0984923-A1 | O-BENZYL OXIME ETHERS AND THEIR USE AS PESTICIDES | Novartis AG (CH) | 2000-03-15 | — | — | EP | claimed |
| EP-0527049-B1 | Quinophthalone compound | MITSUI CHEMICALS INC (JP) | 1998-12-23 | — | — | EP | claimed |
| WO-1998054125-A1 | O-BENZYL OXIME ETHERS AND THEIR USE AS PESTICIDES | NOVARTIS AG (CH) | 1998-12-03 | — | — | WO | claimed |
| EP-0416810-B1 | Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates | BEECHAM GROUP PLC (GB) | 1995-02-08 | — | — | EP | claimed |
| EP-0416810-A2 | Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates | Beecham Group p.l.c. (GB) | 1991-03-13 | — | — | EP | claimed |
| US-4551208-A | FROM AMIDE SOLVENTS | BASF AKTIENGESELLSCHAFT (DE) | 1985-11-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210171515-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | CYP7A1, CYP2E1, CYP11B1 | ADH1C 328/4885ADH1A 172/4885ADH4 292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.